Cancer jab can eradicate entire tumours in patients, trial shows
Key takeaways
- Carl Walsh, 56, who was diagnosed with tongue cancer in May 2024, joined the Orig AMI-4 trial at the Royal Marsden in July 2025.
- Prefer the Guardian on GoogleDoctors have hailed “unprecedented” trial results that show a triple-action cancer jab can eradicate entire tumours in patients.
- In an international trial spanning 11 countries, the injection was offered to patients whose cancer had spread or come back and whose disease had failed to respond to other treatments.
Why this matters: a developing story that could shape the day's news cycle.
Carl Walsh, 56, who was diagnosed with tongue cancer in May 2024, joined the Orig AMI-4 trial at the Royal Marsden in July 2025. Photograph: Handout View image in fullscreen Carl Walsh, 56, who was diagnosed with tongue cancer in May 2024, joined the Orig AMI-4 trial at the Royal Marsden in July 2025. Photograph: Handout Cancer research Cancer jab can eradicate entire tumours in patients, trial shows Jab brought ‘unprecedentedly strong responses’ in patients whose disease had become resistant to chemotherapy and immunotherapy
Prefer the Guardian on GoogleDoctors have hailed “unprecedented” trial results that show a triple-action cancer jab can eradicate entire tumours in patients.
In an international trial spanning 11 countries, the injection was offered to patients whose cancer had spread or come back and whose disease had failed to respond to other treatments.